Swiss Life Asset Management Ltd
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1637689
Zurich, V8
Position in ALNY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$8,828,306
+$975,438 QoQ
Shares Held
29,327
+23.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#203
of 784 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $122,705,584 across 67 Biotechnology names. ALNY ranks #4 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
91,614 | $45,507,422 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,220 | $17,596,298 | |
| 3 | INCY |
Incyte Corp
|
104,901 | $11,891,577 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
29,327 | $8,828,306 | |
| 5 | RPRX |
Royalty Pharma plc
|
136,283 | $7,641,386 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
17,736 | $3,321,598 | |
| 7 | INSM |
INSMED Inc
|
27,552 | $2,937,594 | |
| 8 | MRNA |
Moderna, Inc.
|
25,088 | $1,756,912 |
All Filings in ALNY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,828,306 | 29,327 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $7,852,868 | 23,734 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,935,990 | 22,472 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $9,813,576 | 21,521 | Shares | Defined | 2025-12-02 | |
| 2025-06-30 | $7,757,354 | 23,789 | Shares | Defined | 2025-12-02 | |
| 2025-03-31 | $2,648,895 | 9,810 | Shares | Sole | 2025-12-02 | |
| 2024-12-31 | $3,015,261 | 12,814 | Shares | Sole | 2025-12-09 | |
| 2024-09-30 | $995,607 | 3,620 | Shares | Sole | 2025-12-09 | |
| 2024-06-30 | $473,607 | 1,949 | Shares | Defined | 2025-12-09 | |
| 2023-12-31 | $652,707 | 3,410 | Shares | Defined | 2025-12-09 | |
| 2023-09-30 | $741,694 | 4,188 | Shares | Defined | 2025-12-09 | |
| 2023-06-30 | $819,970 | 4,317 | Shares | Sole | 2025-12-09 | |
| 2023-03-31 | $869,789 | 4,342 | Shares | Defined | 2025-12-09 | |
| 2022-12-31 | $949,887 | 3,997 | Shares | Defined | 2025-12-09 | |
| 2022-09-30 | $352,081 | 1,759 | Shares | Defined | 2025-12-09 | |
| 2022-06-30 | $272,301 | 1,867 | Shares | Defined | 2025-12-09 | |
| No filing history on record for this holder in this stock. | ||||||